Skip to main content
. 2021 Jul 6;20(3):146–153. doi: 10.18502/cjn.v20i3.7690

Table 2.

Summary of base case analysis results

Cladribine tablets Natalizumab
Total Discounted
Cost (USD) 69.842 76.449
LYG 4.655 4.655
QALY 2.720 2.716
Inc. (Cladribine Tablets vs. Natalizumab)
Inc. Cost (USD) - -6.606
Inc. LYG - 0.000
Inc. QALY - 0.003
ICER vs Cladribine (QALY) - Cladribine tablets are dominant

ICER: Incremental cost effectiveness ratio; Inc.: Incremental; LYG: Life years gained; QALY: Quality adjusted life years; USD: United States Dollar